|
C9ORF82 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.32100000014435E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.326800E-01 |
| Stage1-vs-Stage3 |
6.557600E-02 |
| Stage1-vs-Stage4 |
2.007300E-04 |
| Stage2-vs-Stage3 |
1.712270E-02 |
| Stage2-vs-Stage4 |
2.181900E-04 |
| Stage3-vs-Stage4 |
2.727500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.22090000010245E-07 |
| Normal-vs-Asian |
5.36449995536259E-10 |
| Caucasian-vs-AfricanAmerican |
7.084000E-01 |
| Caucasian-vs-Asian |
1.092200E-01 |
| AfricanAmerican-vs-Asian |
6.220800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
5.500000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.88737914186277E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62880819942757E-12 |
| Normal-vs-Age(81-100Yrs) |
3.848700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.331000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.148200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.235000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.023600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.535000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.932400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.963900E-03 |
| Classical-VS-Follicular |
1.555350E-03 |
| Classical-VS-Other |
8.648800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.46619999996656E-06 |
| Tall-VS-Other |
9.526000E-02 |
| Tall-VS-Normal |
3.33066907387547E-16 |
| Follicular-VS-Other |
3.766800E-01 |
| Follicular-VS-Normal |
1.13759999997853E-06 |
| Other-VS-Normal |
1.041160E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1094237467878E-15 |
| Normal-vs-N1 |
2.33146835171283E-15 |
| N0-vs-N1 |
3.358100E-02 |
|
|
